These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
450 related items for PubMed ID: 7159214
1. Epidemiological investigations in young children's communities concerning the efficiency of prophylactic immunization with inactivated influenza vaccine (I.C. 80) in a preepidemic season. Măgureanu E, Busuioc C, Ionescu V, Tisu A, Coban V, Stoicescu A, Guguianu E, Calomfirescu N, Bordeianu V, Toma C. Arch Roum Pathol Exp Microbiol; 1982; 41(3):233-8. PubMed ID: 7159214 [No Abstract] [Full Text] [Related]
2. [Vaccinal prevention of influenza in children]. Zykov MP, Vasil'eva RI. Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981 [No Abstract] [Full Text] [Related]
3. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis]. Mukhina LP, Bichurina MA, Rozaeva NR. Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508 [No Abstract] [Full Text] [Related]
4. Live attenuated influenza vaccine in children. Ambrose CS, Walker RE, Connor EM. Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372 [Abstract] [Full Text] [Related]
5. [Effectiveness of inactivated vaccines against influenza]. Fridman EA, Peradze TV. Tr Inst Im Pastera; 1982 Oct; 58():84-94. PubMed ID: 6764983 [No Abstract] [Full Text] [Related]
6. [Protection of the elderly against influenza (a review of the literature)]. Rudenko LG, Zykov MP. Vrach Delo; 1981 Dec; (12):8-11. PubMed ID: 6895807 [No Abstract] [Full Text] [Related]
7. Benefits and risks of live attenuated influenza vaccine in young children. Oster G, Weycker D, Edelsberg J, Nichol KL, Klein JO, Belshe RB. Am J Manag Care; 2010 Sep; 16(9):e235-44. PubMed ID: 21250400 [Abstract] [Full Text] [Related]
8. The system of population protection against influenza. Shadrin AS, Karpukhin GI, Gararinova VM, Ivanova AS, Erophejeva MK, Efremov BV, Ignatjeva GS, Kustikova YuG, Maksakova VL, Turjeva AV. Z Erkr Atmungsorgane; 1985 Sep; 165(2):163-70. PubMed ID: 4082659 [Abstract] [Full Text] [Related]
9. [Experience in using an absorbed influenza chemical vaccine for the immunization of donors in producing anti-influenzal gamma-globulin]. Egorov PA, Isupov FG, Tuĭmedova RA, Afanas'eva GA, Lobanova AM. Tr Inst Im Pastera; 1976 Sep; 47():163-6. PubMed ID: 80045 [No Abstract] [Full Text] [Related]
10. Further researches on live influenza virus vaccines. De Barbieri A, Crovari P, Cuneo-Crovari P, Giacometti G. Dev Biol Stand; 1976 Sep; 39():73-6. PubMed ID: 604136 [Abstract] [Full Text] [Related]
11. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP. Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577 [Abstract] [Full Text] [Related]
12. [Pharyngeal viral population in 3- to 6-year-old children before and after influenza immunization using the NIVGRIP vaccine administered orally]. Pârvu C, Petrescu A, Coban V. Virologie; 1986 Sep; 37(4):263-7. PubMed ID: 3548031 [Abstract] [Full Text] [Related]
13. Update on influenza activity worldwide and World Health Organization and United States recommendations for influenza vaccine composition for the 1987-1988 season. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1987 Apr 10; 36(13):193-5. PubMed ID: 3104754 [No Abstract] [Full Text] [Related]
14. [1st experience with human inoculations with an inactivated influenza vaccine]. Beliakov VD, Ivanov KG, Bundzen NG, Tentser PS, Maliarenko IuD. Tr Inst Im Pastera; 1976 Apr 10; 47():114-21. PubMed ID: 802563 [No Abstract] [Full Text] [Related]
15. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE. Vaccine; 2008 Sep 08; 26(38):4940-6. PubMed ID: 18662737 [Abstract] [Full Text] [Related]
16. Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. Wright PF, Ross KB, Thompson J, Karzon DT. N Engl J Med; 1977 Apr 14; 296(15):829-34. PubMed ID: 846492 [Abstract] [Full Text] [Related]
17. Influenza vaccine 2007-2008. Med Lett Drugs Ther; 2007 Oct 08; 49(1271):81-3. PubMed ID: 17912142 [No Abstract] [Full Text] [Related]
18. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season]. Lupulescu E, Ioniţă E, Botez D, Matepciuc M, Tabra ME, Tecu C, Alexandrescu V, Munţiu A. Bacteriol Virusol Parazitol Epidemiol; 1997 Oct 08; 42(1-2):110-2. PubMed ID: 9235136 [No Abstract] [Full Text] [Related]
19. Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep; 2007 Jul 01; 33(ACS-7):1-38. PubMed ID: 17663034 [No Abstract] [Full Text] [Related]
20. [Prophylactic effectiveness of an inactivated formol influenza vaccine]. Agafonov VI, Perepelkin VS, Chemeris EA, Novikov NL. Voen Med Zh; 1981 Feb 01; (2):36-8. PubMed ID: 7233843 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]